Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 22.55 HKD -5.85% Market Closed
Market Cap: 875.7m HKD
Have any thoughts about
Shanghai HeartCare Medical Technology Corp Ltd?
Write Note

Shanghai HeartCare Medical Technology Corp Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai HeartCare Medical Technology Corp Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Long-Term Investments
ÂĄ2.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Long-Term Investments
ÂĄ159.8m
CAGR 3-Years
70%
CAGR 5-Years
66%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Long-Term Investments
ÂĄ1.8B
CAGR 3-Years
24%
CAGR 5-Years
38%
CAGR 10-Years
80%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Long-Term Investments
ÂĄ496.8m
CAGR 3-Years
101%
CAGR 5-Years
71%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Long-Term Investments
ÂĄ116.1m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Long-Term Investments
ÂĄ102.1m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai HeartCare Medical Technology Corp Ltd
Glance View

Market Cap
875.7m HKD
Industry
Health Care

Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

Intrinsic Value
33.74 HKD
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Shanghai HeartCare Medical Technology Corp Ltd's Long-Term Investments?
Long-Term Investments
2.5m CNY

Based on the financial report for Dec 31, 2023, Shanghai HeartCare Medical Technology Corp Ltd's Long-Term Investments amounts to 2.5m CNY.

What is Shanghai HeartCare Medical Technology Corp Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 1Y
531%

Over the last year, the Long-Term Investments growth was 531%.

Back to Top